Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Director | January 27, 2026 | January 29, 2026 |
| Fortrea Holdings Inc.FTRE · Entity 4623 | Director | February 21, 2025 | February 25, 2025 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | May 26, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date January 27, 2026 · Filed January 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,423 |
Reported balance
After 2026-01-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 1,098 · Balance 10,423 F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2: Includes units acquired through dividend investment since the last report filed by the reporting person.
Fortrea Holdings Inc.
Report date February 21, 2025 · Filed February 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,636 |
Reported balance
After 2025-02-21 transaction · row 1
1 source rowRow 1 · 2025-02-21 · Exercise / conversion · Acquired 7,282 · Balance 13,636 F1: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-21 · Exercise / conversion · Disposed 7,282 · Balance 0 F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock. F1: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis |
Filing footnotes · ownership attribution and instrument terms
F1: The Management Development and Compensation Committee of Board of Directors approved, immediately upon the Reporting Person's resignation from the Board of Directors, accelerated vesting of 7,282 Restricted Stock Units that were otherwise scheduled to vest on May 18, 2025. These Restricted Stock Units converted into common stock on a one-for-one basis
F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 412,183 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 46,293 · Balance 412,183 F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date December 02, 2020 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,771 |
Reported balance
After 2020-12-02 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2020-12-02 · Gift · Disposed 277 · Balance 12,771 |
| Common StockSEC Table I · non-derivative | Direct | 13,826 |
Reported balance
After 2021-04-15 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2021-04-15 · Gift · Disposed 170 · Balance 13,826 |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 13,826 · Balance 0 F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 1,022 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 23, 2018 Filed Jan 25, 2018 15:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 941 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-18-000019 · edgar.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,867 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| October 06, 2017 Filed Oct 6, 2017 19:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 5,651 | $0.00 Strike: $62.74 | $0.00 |
DisclosureSEC source: 0001127602-17-029580 · form4.xml · derivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,651 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and round up to the nearest cent. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and round up to the nearest cent. F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and round up to the nearest cent. Read SEC document |
| October 06, 2017 Filed Oct 6, 2017 19:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 5,651 | $102.39 | $578,594.02 |
DisclosureSEC source: 0001127602-17-029580 · form4.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,999 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 5,651 shares were sold in multiple transactions executed on the same day at prices ranging from $102.05 to $102.78. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| October 06, 2017 Filed Oct 6, 2017 19:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 5,651 | $62.74 | $354,543.74 |
DisclosureSEC source: 0001127602-17-029580 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and round up to the nearest cent. F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and round up to the nearest cent. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 17:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-026128 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,999 Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 17:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007774 · form4.xml · derivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,326 Underlying: Common Stock · 2,161 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 17:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007774 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantDeferred Stock Units · Derivative | 1,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005631 · form4.xml · derivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,487 Underlying: Common Stock · 1,990 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F3 · balance_after: Includes deferred stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Deferred stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 18:51 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000002 · edgar.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 04, 2016 Filed Nov 10, 2016 21:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-066737 · form4.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,143 Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:48 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-16-000130 · edgar.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| May 07, 2014 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 8 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,435 Read SEC document |
| May 07, 2014 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 7 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,560 Read SEC document |
| November 06, 2012 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 76 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 6 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,623 Read SEC document |
| November 05, 2012 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 152 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 5 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,699 Read SEC document |
| May 17, 2012 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 77 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 4 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,851 Read SEC document |
| February 13, 2012 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 110 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 3 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,928 Read SEC document |
| November 25, 2011 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 88 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 2 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,038 Read SEC document |
| November 23, 2011 Filed Nov 1, 2019 13:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031437 · form5.xml · nonDerivative · entry 1 ECKERT R ANDREW · CIK 0001210525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,126 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.